Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients

被引:127
作者
Emelyanov, A
Fedoseev, G
Abulimity, A
Rudinski, K
Fedoulov, A
Karabanov, A
Barnes, PJ
机构
[1] Pavlov Med Univ, Hosp Therapeut Clin, St Petersburg 197089, Russia
[2] Natl Heart & Lung Inst, Dept Thorac Med, London, England
关键词
asthma; expired breath condensate; hydrogen peroxide;
D O I
10.1378/chest.120.4.1136
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Airway inflammation is important in the development and progression of asthma. Activation of inflammatory cells induces a respiratory burst resulting in the production of reactive oxygen species, such as H2O2. The aim of this study was to measure the concentration of H2O2 in exhaled breath condensate and its correlation with airway obstruction, airway hyperresponsiveness, and concentration of eosinophil cationic protein (ECP) in serum in 70 steroid-naive, atopic patients with unstable asthma (20 men; age range, 18 to 62 years) and 17 normal subjects (7 men; age range, 19 to 34 years). Methods: Exhaled H2O2 was measured using a colorimetric assay, and the concentration of ECP in serum was measured using radioimmunoassay. Airway hyperresponsiveness was expressed as the provocative concentration of inhaled histamine causing a 20% fall in FEV1 (PC20). Results: In patients with asthma, the mean H2O2 concentration was significantly elevated compared to values in normal subjects: 0.127 +/- 0.083 mol/L vs 0.024 +/- 0.016 mol/L (p < 0.001). There was a significant correlation among H2O2 concentration, FEV1, PC20, and ECP in serum. Conclusion: We conclude that exhaled H2O2 is significantly elevated in asthmatic patients. This is correlated with disease severity and indirect markers of airway inflammation. Measurement of exhaled H2O2 may be useful to assess airway inflammation and oxidative stress in asthmatic patients.
引用
收藏
页码:1136 / 1139
页数:4
相关论文
共 26 条
[1]  
ADELROTH E, 1990, AM REV RESPIR DIS, V14, P291
[2]  
[Anonymous], 1987, AM REV RESPIR DIS, V136, P225
[3]  
ANTZAK A, 1999, ARCH IMMUNOL THER EX, V47, P119
[4]  
ANTZAK A, 1997, EUR RESPIR J, V9, P1235
[5]  
BALDWIN SR, 1986, LANCET, V1, P11
[6]  
Barnes PJ, 1998, PHARMACOL REV, V50, P515
[7]  
DEBACKER W, 1998, EUR RESPIR REV, V8, P1098
[8]   Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. [J].
Dekhuijzen, PNR ;
Aben, KKH ;
Dekker, I ;
Aarts, LPHJ ;
Wielders, PLML ;
vanHerwaarden, CLA ;
Bast, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) :813-816
[9]   MUCOSAL INFLAMMATION IN ASTHMA [J].
DJUKANOVIC, R ;
ROCHE, WR ;
WILSON, JW ;
BEASLEY, CRW ;
TWENTYMAN, OP ;
HOWARTH, PH ;
HOLGATE, ST .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (02) :434-457
[10]   EXPIRED BREATH HYDROGEN-PEROXIDE IS A MARKER OF ACUTE AIRWAY INFLAMMATION IN PEDIATRIC-PATIENTS WITH ASTHMA [J].
DOHLMAN, AW ;
BLACK, HR ;
ROYALL, JA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04) :955-960